Drug Safety

What are the Real Lessons from Vioxx^®?
pp. 651-658(8)
Author: Edwards, I. Ralph

The Effect of HMG-CoA Reductase Inhibitors on Coenzyme Q10: Possible Biochemical/Clinical Implications
pp. 659-676(18)
Authors: Hargreaves, Iain P.; Duncan, Andrew J.; Heales, Simon J.R.; Land, John M.

Undesirable Effects of Citrus Juice on the Pharmacokinetics of Drugs: Focus on Recent Studies
pp. 677-694(18)
Authors: Saito, Mitsuo; Hirata-Koizumi, Mutsuko; Matsumoto, Mariko; Urano, Tsutomu; Hasegawa, Ryuichi

Treating Mood Disorders During Pregnancy: Safety Considerations
pp. 695-706(12)
Authors: Eberhard-Gran, Malin; Eskild, Anne; Opjordsmoen, Stein

Fetal Safety of Drugs Used in the Treatment of Allergic Rhinitis: A Critical Review
pp. 707-719(13)
Authors: Gilbert, Cameron; Mazzotta, Paolo; Loebstein, Ronen; Koren, Gideon

Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis
pp. 721-730(10)
Authors: Cranney, Ann; Adachi, Jonathan D.

Trends in Spontaneous Adverse Drug Reaction Reports to the French Pharmacovigilance System (1986–2001)
pp. 731-740(10)
Authors: Thiessard, Frantz; Roux, Emmanuel; Miremont-Salamé, Ghada; Fourrier-Réglat, Annie; Haramburu, Françoise; Tubert-Bitter, Pascale; Bégaud, Bernard

Tolerability of Treatments for Postherpetic Neuralgia
pp. 741-741(1)
Author: Alvarez, Nancy A.

The Authors’ Reply
pp. 742-742(1)
Authors: Johnson, Robert W.; Cunningham, Anthony L.